[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100536840":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":35,"responsibleParty":76,"collaborators":10,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":10,"eligibilityCriteria":84,"healthyVolunteers":85,"sex":86,"minAge":87,"maxAge":10,"enrollmentInfo":88,"targetDuration":10,"studyType":91,"phases":10,"briefSummary":92,"conditions":93,"keywords":95,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Gynuity Health Projects","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"early medication abortion via telemedicine",null,"Medication abortion up to 84 days gestation using misoprostol alone regimen consisting of three doses 800mcg (4 tablets of 200mcg misoprostol each) taken every 3 hours. An extra dose (800mcg) may also be taken if there was no bleeding after administering the earlier doses.",[13],"Drug: Misoprostol",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Misoprostol","Self-administered misoprostol by clients obtaining medication abortion via telemedicine",[9],[21],"Cytotec",[23],{"name":24,"affiliation":5,"role":25},"Beverly Winikoff, MD, MPH","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Jill Durocher","CONTACT","12124481230","jdurocher@gynuity.org",{"name":33,"role":29,"phone":30,"phoneExt":10,"email":34},"Manuel Bousieguez","mbousieguez@gynuity.org",[36,53,66],{"facility":37,"status":38,"city":39,"state":10,"zip":10,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"El Comité de Derechos Sexuales y Reproductivos de Ecuador (CODESER)","RECRUITING","Ambato","Ecuador","EC",{"type":43,"coordinates":44},"Point",[45,46],-78.61675,-1.24908,{"lat":46,"lon":45},[49],{"name":50,"role":29,"phone":51,"phoneExt":10,"email":52},"Maria Fernanda Morales","593 998220369","mafer_moca@yahoo.es",{"facility":54,"status":38,"city":55,"state":10,"zip":10,"country":40,"countryCode":41,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Cemoplaf","Quito",{"type":43,"coordinates":57},[58,59],-78.52495,-0.22985,{"lat":59,"lon":58},[62],{"name":63,"role":29,"phone":64,"phoneExt":10,"email":65},"Gabriela Rivera","593 995512828","gabyrivera2398@hotmail.com",{"facility":67,"status":38,"city":55,"state":10,"zip":10,"country":40,"countryCode":41,"cosmosGeoPoint":68,"geoPoint":70,"contacts":71},"Federación Nacional de Obstetrices y Obstetras del Ecuador (FENOE)",{"type":43,"coordinates":69},[58,59],{"lat":59,"lon":58},[72],{"name":73,"role":29,"phone":74,"phoneExt":10,"email":75},"Paola Tito","593 22951737","paojaime@hotmail.es",{"type":77,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100536840","evaluation-of-telemedicine-medical-abortion-service-in-ecuador-100536840",false,"NCT06270056","Evaluation of Telemedicine Medical Abortion Service in Ecuador","Evaluation of Telemedicine Services to Address Urgent Issues Related to Sexual and Reproductive Rights in Ecuador","Inclusion Criteria:\n\n* Woman is seeking abortion care and wants to use telemedicine service for her medication abortion procedure.\n* Woman has access to an internet connection or a device that allows remote consultation.\n* Woman is 15 years of age or older.\n* Woman can provide an address to which abortion medications will be mailed.\n* Woman reports having no contraindications to a medical abortion.\n* The study provider does not suspect ectopic pregnancy or a nonviable pregnancy.\n* The gestational age allows sufficient time for the woman to take the misoprostol no later than 84 days of gestation.\n* A feasible plan is made that the woman agrees to confirm complete abortion and to seek care to manage incomplete abortion complications.\n* The woman understands the study procedures and is likely to comply with study instructions and has granted informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Medically ineligible for procedure.\n* Provider determines that a medical abortion using the telemedicine approach is not appropriate for that person.",true,"FEMALE","15 Years",{"count":89,"type":90},100,"ESTIMATED","OBSERVATIONAL","This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.",[94],"Pregnancy",[96],"abortion","2024-10-11",{"date":99,"type":100},"2024-10-15","ACTUAL",{"date":102,"type":100},"2024-07-24",{"date":104,"type":90},"2025-09",{"name":5,"class":6},3]